In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Urgent drug warning: ‘MDMA (Ecstasy) powder’ found to contain: 25C-NBOMe a synthetic hallucinogen; and 4-fluoroamphetamine, a stimulant. Several hospitalisations have been reported in the Sydney region.
The NBOMe drugs can cause vivid hallucinations, violence, fear and agitation, the combination of which can lead to accidents, harm to self and others.
These drugs are potent and can be life threatening.
4-fluoroamphetamine causes similar effects to MDMA and amphetamine.
You are at increased risk of harm:
If you use drugs alone
As your dose increases
If you use with other substances that cause hallucinations e.g. LSD, ketamine; or stimulants e.g. MDMA, cocaine or methamphetamine.
The current cluster in NSW appears to be a light brown powder misrepresented as MDMA. NBOMe drugs are usually found in the form of blotting paper, liquid and tablets. They can also be misrepresented as LSD.
Effects to look out for:
Serious adverse effects may include violent behaviour, vivid hallucinations, fever, agitation, derealisation and depersonalisation.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…